NEUROPLASTICITY AND CHRONIC STRESS: MECHANISMS OF BRAIN DAMAGE AND PATHWAYS TO RECOVERY

Authors
  • Iminova Sevara Shukhratbek kizi

    Tashkent State Medical University

    Author

  • Tairova Madina Ilkhomovna

    Tashkent State Medical University

    Author

Keywords:
Major depressive disorder (MDD); Neuroplasticity; Chronic stress; BDNF; Hippocampal atrophy; SV2A; mTORC1; Synaptogenesis; HPA axis; Neurorestoration; Treatment-resistant depression; Biological resilience.
Abstract

Major depressive disorder (MDD) is increasingly recognized as a systemic pathology of impaired homeostatic neuroplasticity induced by chronic stress. This review synthesizes current evidence demonstrating how hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis triggers glucocorticoid neurotoxicity and the profound downregulation of Brain-Derived Neurotrophic Factor (BDNF). Structurally, these molecular shifts precipitate an 8–10% volumetric deficit in the hippocampus (Videbech & Ravnkilde, 2004), alongside dendritic retraction and a reduction in synaptic density within the prefrontal cortex (PFC).

References

1.Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338(6103):68–72. doi:10.1126/science.1222939

2.Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos Trans R Soc Lond B Biol Sci. 2012;367(1601):2475–2484. doi:10.1098/rstb.2011.0357

3.Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008;33(1):88–109. doi:10.1038/sj.npp.1301574

4.Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57(10):925–935. doi:10.1001/archpsyc.57.10.925

Downloads
Published
2026-04-10
Section
Articles
License
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

NEUROPLASTICITY AND CHRONIC STRESS: MECHANISMS OF BRAIN DAMAGE AND PATHWAYS TO RECOVERY. (2026). Eureka Journal of Health Sciences & Medical Innovation, 2(4), 112-128. https://eurekaoa.com/index.php/5/article/view/767

Most read articles by the same author(s)